Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study.
Gridelli C, Cigolari S, Maiorino A, Ianniello GP, Brancaccio L, Rossi A, De Cataldis G, Pedicini T, Maiorino L, Barletta E, Di Lanno M, Bilancia D, Crispino C, Barzelloni ML, Masullo P, D'Aniello R, Manzione L. Gridelli C, et al. Among authors: maiorino a, maiorino l. Lung Cancer. 2000 Jun;28(3):237-44. doi: 10.1016/s0169-5002(99)00131-2. Lung Cancer. 2000. PMID: 10812192 Clinical Trial.
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
Ianniello GP, De Cataldis G, Comella P, Scarpati MD, Maiorino A, Brancaccio L, Cioffi R, Lombardi A, Carnicelli P, Tinessa V. Ianniello GP, et al. Among authors: maiorino a. Cancer. 1996 Jul 1;78(1):63-9. doi: 10.1002/(SICI)1097-0142(19960701)78:1<63::AID-CNCR11>3.0.CO;2-5. Cancer. 1996. PMID: 8646728 Clinical Trial.
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G. Comella P, et al. Among authors: maiorino a. Cancer. 1994 Oct 1;74(7):1874-81. doi: 10.1002/1097-0142(19941001)74:7<1874::aid-cncr2820740708>3.0.co;2-u. Cancer. 1994. PMID: 8082093 Clinical Trial.
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis.
Santo A, Pedersini R, Pasini F, Terzi A, Pari F, Cartei G, Sibau A, Molino A, Maiorino A, Panza N, Oletti MV, Maluta S, Calabrò F, Cetto GL. Santo A, et al. Among authors: maiorino a. Lung Cancer. 2001 Dec;34 Suppl 4:S15-20. doi: 10.1016/s0169-5002(01)00400-7. Lung Cancer. 2001. PMID: 11742697 Clinical Trial.
CD34 Expression in the Stromal Cells of Alveolar Adenoma.
De Rosa N, Maiorino A, De Rosa I, Curcio C, Sellitto C, Amore D. De Rosa N, et al. Among authors: maiorino a. Case Rep Med. 2012;2012:913517. doi: 10.1155/2012/913517. Epub 2012 Oct 16. Case Rep Med. 2012. PMID: 23118769 Free PMC article.
Age-related risk factors for ischemic stroke in Italian men.
Carrieri PB, Orefice G, Maiorino A, Provitera V, Balzano G, Lucariello A. Carrieri PB, et al. Among authors: maiorino a. Neuroepidemiology. 1994;13(1-2):28-33. doi: 10.1159/000110355. Neuroepidemiology. 1994. PMID: 8190203
Cytokines in the pathogenesis of multiple sclerosis.
Carrieri PB, Maiorino A, Provitera V, Soscia E, Perrella O. Carrieri PB, et al. Among authors: maiorino a. Acta Neurol (Napoli). 1992 Aug-Dec;14(4-6):333-41. Acta Neurol (Napoli). 1992. PMID: 1293976 Review.
36 results